TL;DR
This paper introduces a novel computational approach to model gene expression regulation by integrating diverse biological data. The method builds predictive linear models to uncover relationships between target genes, their methylation status, and the expression of other genes and transcription factors, revealing both known and novel biological connections relevant for cancer research.
What Problem Does This Paper Address?
Understanding how genes are regulated is crucial for deciphering complex diseases like cancer and identifying potential therapeutic targets. Gene expression is influenced by a multitude of factors, making the regulatory process incredibly complex. Existing methods often struggle to integrate various data types or handle the sheer complexity of these regulatory networks. This paper aims to address this by developing a robust and interpretable computational framework that can systematically analyze these intricate relationships.
Methods
The core of this work is a novel, multi-step quantitative analysis approach for modeling gene expression regulation. It employs a predictive linear modeling strategy. A key innovation is its incremental feature selection with re-evaluation. Instead of considering all potential regulatory features at once, the approach progressively builds models by adding groups of features (e.g., promoter methylation, same-pathway genes, transcription factors) and re-evaluating the most relevant ones from previous steps. This iterative process helps manage computational complexity and disentangle the contributions of different feature types.
The analysis is structured around five incremental data matrices (M1-M5), each incorporating different types of regulatory information. The method then performs feature selection (specifically, an incremental forward approach with re-evaluation) followed by linear regression to identify significant regulatory features and quantify their impact on target gene expression. The significance of features is determined by their regression coefficients and associated confidence intervals.
Datasets
The study utilizes publicly available datasets:
- GENCODE: For genomic annotations and transcription start sites (TSSs).
- ENCODE: For transcription factor binding data.
- TCGA (The Cancer Genome Atlas): For gene expression and promoter methylation data from various tumor types.
The primary application is on Ovarian Serous Cystadenocarcinoma (OV), using 372 patient samples. To validate the approach, data from basal-like Breast Invasive Carcinoma (BRCA) (122 samples) was also used, as this subtype shares molecular similarities with OV. ChIP-seq data from MCF-7 and K562 cell lines were used to identify candidate transcription factors.
Key Insights and Ideas
- Integrated Data Approach: The power of combining diverse data sources (gene expression, methylation, TF binding) is demonstrated for a more comprehensive view of regulation.
- Incremental Feature Selection: The novel feature selection strategy is crucial for managing complexity and identifying the most impactful regulators without being overwhelmed by the vast number of potential features.
- Pathway Interconnections: The study highlights that gene regulation isn't confined to single pathways, revealing interconnections between DNA REPAIR, STEM CELLS, and GLUCOSE METABOLISM pathways.
- Directionality in Regulation: Experimental validation suggests that some identified correlations might imply a directional influence, where one gene (e.g., CDK12) might regulate another (e.g., SUZ12).
- Model Generalizability: The developed models show promise in generalizing to similar tumor types (OV and basal-like BRCA), suggesting the underlying biological mechanisms are conserved to some extent.
Key Results
- The approach successfully built predictive linear models for gene expression regulation in Ovarian cancer, identifying relevant features.
- DNA REPAIR pathway: Identified 9 genes with good linear fits, with promoter methylation being a significant regulator for several, and frequent regulators including POLQ and FANCD2.
- STEM CELLS pathway: Identified 11 genes with good fits, with promoter methylation being a key regulator for 10 of them. PAX8 was identified as a frequent regulator.
- GLUCOSE METABOLISM pathway: Identified 10 genes with good fits, with promoter methylation being a significant regulator for 12 genes. ILK was identified as a frequent regulator.
- Cross-application on BRCA: Models developed for OV showed similar performance when applied to BRCA data for several key genes, confirming robustness.
- Comparison with ARACNe: The proposed method showed high similarity in identifying relevant regulatory features and their rankings compared to ARACNe, a well-established information-theoretic method. Notably, the proposed method identified relationships (e.g., CHEK1 and DNMT1) that ARACNe missed.
- Experimental Validation: Several predicted correlations were experimentally confirmed, including ERCC1-ERCC2 and SUZ12-CDK12, and CHEK1-DNMT1.
Limitations and Future Work
- Model Completeness: The models do not fully explain the regulatory networks, with Adjusted R² scores generally below 0.8. This is acknowledged as expected, given that gene expression is influenced by many factors beyond those included (e.g., non-coding RNAs, protein levels, post-translational modifications).
- Data Availability: The study acknowledges the limited number of OV samples, which necessitated using external ChIP-seq data.
- Future Work:
- Further testing of the developed models on new, held-out datasets to assess generalization.
- Comparative testing of different feature selection methods (including the proposed incremental approach) on these datasets.
- Application to a wider range of tumor types and gene sets, including universally activated pathways like cell cycle regulation, to identify conserved versus specific regulatory features.
Summary updated